From theheart.org on Medscape

Coverage from the

Transcatheter Cardiovascular Therapeutics (TCT) 2019

September 25 - 29, 2019; San Francisco, California

September 25 - 29, 2019 San Francisco, California

TCT 2019 Zero-Contrast PCI in CKD Patients Helps Avoid Later Dialysis No coronary lesion seemed too complex for the procedure that used intravascular ultrasound and pressure readings to guide stenting, usually avoiding need for contrast injection, protecting the kidneys.
Medscape Medical News, October 4, 2019
TCT 2019 TWILIGHT Hits Primary Endpoint, Alters Aspirin Post PCI The perennial question of how soon aspirin can be dropped in dual antiplatelet therapy became more definitive, but experts caution against extrapolating results to very early aspirin discontinuation.
Medscape Medical News, September 26, 2019

Meeting Highlights At A Glance

Top News From TCT 2019: Slideshow Research predicted to alter the landscape of aspirin therapy after PCI, plus support for pacemaker-based therapy for hypertension featured prominently at TCT 2019.

Conference News

TCT 2019 More Evidence for Superiority of IVUS Over Angiography in PCI
Medscape Medical News, December 18, 2019
TCT 2019 Transcatheter Tricuspid Fix Bests Meds Alone in Early Results
Medscape Medical News, October 10, 2019
TCT 2019 OCT Bests FFR Guidance in Optimizing PCI: FORZA
Medscape Medical News, October 10, 2019
TCT 2019 CTCA Does Not Reduce Time to Diagnosis in Suspected ACS
Medscape Medical News, October 9, 2019
TCT 2019 Zero-Contrast PCI in CKD Patients Helps Avoid Later Dialysis
Medscape Medical News, October 4, 2019
TCT 2019 COAPT: MitraClip Adds Years of Life, but at a Steep Price
Medscape Medical News, October 4, 2019
TCT 2019 TAVR-Surgery Parity at 5 Years, Good Echo Result Key: PARTNER 2A
Medscape Medical News, October 3, 2019
TCT 2019 PARTNER 3: Leaflet Thrombosis Often Resolves, the Questions Haven't
Medscape Medical News, October 2, 2019
TCT 2019 No Increased Mortality With Paclitaxel Balloon Angioplasty in PAD
Medscape Medical News, October 2, 2019
TCT 2019 Complete Revascularization After STEMI Confers Long-term Benefit
Medscape Medical News, October 1, 2019
TCT 2019 MODERATO II: Pacemaker-based Therapy Tamps Down Hypertension
Medscape Medical News, October 1, 2019

TCT 2019 EXCEL at 5 Years: PCI, CABG 'Relatively Comparable' in LM Disease
Medscape Medical News, September 30, 2019
TCT 2019 COAPT at 3 Years: MitraClip Benefits Persist, Crossovers Profit
Medscape Medical News, September 30, 2019
TCT 2019 SCOPE I: Acurate Neo Takes a Beating Against SAPIEN 3
Medscape Medical News, September 28, 2019
TCT 2019 AUGUSTUS: Best Benefit With Apixaban, P2Y12 Inhibitor Dual Therapy
Medscape Medical News, September 28, 2019
TCT 2019 Experience, High Volume Improve Mitral Valve Procedural Outcomes
Medscape Medical News, September 28, 2019
TCT 2019 Mitral Valve-in-Valve Replacement Upheld in High-Risk Patients
Medscape Medical News, September 28, 2019
TCT 2019 Resolute Onyx as Good as BioFreedom in High-Bleeding-Risk Patients
Medscape Medical News, September 27, 2019
TCT 2019 Solo Aspirin After 3 Months DAPT Safe in High-Bleed-Risk Patients
Medscape Medical News, September 27, 2019
TCT 2019 TWILIGHT Hits Primary Endpoint, Alters Aspirin Post PCI
Medscape Medical News, September 26, 2019
TCT 2019 Lithotripsy Is a Blast for Tough Coronary Calcium: Disrupt-CAD 2
Medscape Medical News, September 26, 2019

© WebMD, LLC

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Perspectives

Ticagrelor Sans Aspirin Trial Answers Some Questions About DAPT
Robert A. Byrne, MB BCh, PhD

Top Trials Presented at TCT
Prof Mamas Mamas

Popular News from TCT 2018

COAPT Stuns, Resurrects MitraClip in HF With Mitral Regurgitation After a dismal showing in the recent MITRA-FR study, dramatic reductions in heart failure hospitalizations and death had even the researchers asking, 'Why are the COAPT results so different?
Medscape Medical News, Sep 23, 2018
IMPERIAL: Slow-Eluting Stent Outpaces Standard for Fem-Pop Lesions Although the randomized head-to-head results for the investigational Eluvia stent were broadly welcomed in a field described as having a plethora of therapies but a paucity of data, caveats were raised.
Medscape Medical News, Sep 22, 2018
Split Decision on Renal Denervation for Resistant Hypertension Ultrasound ablation showed an early advantage in RADIOSOUND-HTN, whereas REDUCE HTN-REINFORCE missed its primary end point but offered an intriguing late effect.
Medscape Medical News, Sep 27, 2018

Previous Coverage

Related Resource

Interventional Cardiology News & Perspectives